Protein C derivatives
US6998122B1 · kind B1 · utility
1Cited by
9References
39Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 13, 2000 |
| Grant date | Feb 14, 2006 |
| Priority date | — |
| Expiry date | Apr 13, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel protein C derivatives are described. These polypeptides retain the biological activity of the wild-type human protein C with substantially longer half-lives in human blood. These polypeptides will require either less frequent administration and/or smaller dosage than wild-type human protein C in the treatment of vascular occlusive disorders, hypercoagulable states, thrombotic disorders and disease states predisposing to thrombosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.